查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2045928

基因表現分析市場－全球產業規模、佔有率、趨勢、機會和預測：按產品類型、技術、應用、最終用戶、地區和競爭格局分類，2021-2031年

Gene Expression Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Technique, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球基因表現分析市場預計將從 2025 年的 55.2 億美元成長到 2031 年的 87.2 億美元，複合年成長率達到 7.92%。

基因表現分析透過定量測量傳訊RNA(mRNA) 的水平來評估生物樣本中特定基因的活性。它是闡明細胞功能和理解各種疾病潛在機制的關鍵步驟。該市場的主要驅動力是精準醫療需求的不斷成長以及製藥業對標靶藥物研發的重視。此外，基因測序成本的降低也促使其在生物標記鑑定和檢驗中廣泛應用，加速了市場成長。

市場概覽
預測期 2027-2031
市場規模：2025年 55.2億美元
市場規模：2031年 87.2億美元
複合年成長率：2026-2031年 7.92%
成長最快的細分市場 裝置
最大的市場 北美洲

隨著慢性疾病發生率的上升，尤其是在腫瘤領域，對強大的基因組分析工具的需求日益成長，這些工具能夠指導治療決策。美國癌症協會預測，2025年，美國將新增2,041,910例癌症病例。如此巨大的疾病負擔增加了對基因表現分析的需求，但市場在解讀複雜大規模的數據方面面臨巨大的挑戰。缺乏能夠分析這些龐大資料集的熟練生物資訊專業人員是限制全球基因表現分析市場全面擴張的主要瓶頸。

市場促進因素

次世代定序(NGS) 和 PCR 平台的技術進步正透過提高通量和簡化基因組分析，從根本上改變全球基因表現分析市場。這些創新使實驗室能夠以驚人的速度和準確性處理大量的生物數據，從而加速表達分析在臨床和研究領域的應用。正如領先的創新者所展示的那樣，高性能定序儀器是市場擴張的主要驅動力。牛津奈米孔技術公司 (Oxford Nanopore Technologies) 公佈的 2024 會計年度全年業績（不計外匯波動的影響）成長了 23%，這主要得益於新型感測平台的應用。同時，Illumina 公司 2024 會計年度全年營收達 43 億美元，凸顯了全球對先進基因組基礎設施的強勁需求。

此外，政府和私人機構對基因組研究的大力投入是另一個關鍵驅動動力，為精準醫療計劃和人群健康調查的拓展提供了必要的資金。公共部門的努力對於將生物標記檢驗和基因表現分析整合到國家醫療保健系統中，以及降低開發新型診斷工具的相關風險至關重要。此類投資有助於營造穩定的成長環境，並確保專案的長期可行性。英國政府在2030年投入6.5億英鎊大規模就是一個典型的例子，旨在推動基因組醫學發展，擴大新生兒定序範圍，加速發現基因與疾病之間的關聯，並強制要求在公共衛生領域更廣泛地應用表達分析技術。

市場挑戰

全球基因表現分析市場正受到生物資訊專業人才短缺的嚴重限制。儘管基因組數據的生成速度飛快，但處理和解讀這些海量資訊的能力卻落後，導致大量表達數據未能充分利用，形成瓶頸。這種差距延緩了將原始定序結果轉化為可操作的生物學見解的過程，阻礙了製藥公司和研究機構高效檢驗生物標記，最終延緩了藥物研發和臨床應用。

由於各機構競相爭奪能夠管理複雜、高通量表達數據分析的有限專家資源，熟練人才的短缺正在推高營運成本並延長專案工期。根據皮斯托亞聯盟的一項調查，到2025年，34%的生命科學專業人士將把缺乏熟練人才視為採用先進數據分析技術的主要障礙，這將阻礙醫療保健和研究領域市場的全面擴充性。

市場趨勢

將人工智慧 (AI) 和機器學習 (ML) 整合到數據分析中，能夠將複雜的基因組資料集轉化為可執行的見解，從而迅速提升市場價值。隨著基因表現數據的指數級成長，AI 驅動的平台正在取代傳統的生物資訊方法，以有效地識別新的生物標記和治療標靶。這一趨勢凸顯了經營模式：精細的數據解讀與定序同等重要，直接應對了數據複雜性所帶來的挑戰。例如，Tempus AI 公司報告稱，其 2024 年的總收入將達到 6.934 億美元，年成長 30.4%，主要成長來自演算法資訊服務。

同時，用於組織圖譜繪製的空間轉錄組學的蓬勃發展，正透過實現組織精確物理結構內基因活性的可視化，徹底革新生物學研究。該技術克服了批量定序的局限性，保留了理解腫瘤微環境等複雜條件所必需的空間背景資訊。此外，市場上用於這些高解析度研究的專用硬體正顯著增加，從而為單細胞生物學和空間生物學建立永續的基礎設施。例如，10x Genomics公司報告稱，到2024年底，其儀器銷量將超過7,000台，這凸顯了這些先進工具在全球實驗室中日益普及。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球基因表現分析市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品類型（設備、服務、其他）
    • 透過技術手段（RNA表現、啟動子分析、蛋白質表現及轉譯後修飾表現等）
    • 按應用領域（藥物發現/開發、臨床診斷、生物技術/微生物學、其他）
    • 按最終用戶分類（製藥和生物技術公司、受託研究機構(CRO)、學術和政府研究機構、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美基因表現分析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲基因表現分析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區基因表現分析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲基因表現分析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美基因表現分析市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球基因表現分析市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Merck KGaA
  • Genscript Biotech Corporation
  • Qiagen NV
  • Bio-Rad Laboratories Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • Promega Corporation
  • Agilent Technologies Inc.
  • Lonza Group Ltd.
  • New England Biolabs Inc

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 16897

The Global Gene Expression Analysis Market is projected to grow from USD 5.52 Billion in 2025 to USD 8.72 Billion by 2031, achieving a Compound Annual Growth Rate (CAGR) of 7.92%. Gene expression analysis involves the quantitative measurement of messenger RNA levels to assess specific gene activity within biological samples, a process essential for elucidating cellular functions and understanding the mechanisms underlying various diseases. This market is primarily supported by the escalating demand for precision medicine and the intensive focus on targeted drug discovery within the pharmaceutical industry. Furthermore, decreasing genomic sequencing costs enable broader adoption for biomarker identification and validation, thereby propelling market growth.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 5.52 Billion
Market Size 2031USD 8.72 Billion
CAGR 2026-20317.92%
Fastest Growing SegmentInstruments
Largest MarketNorth America

The rising prevalence of chronic conditions, particularly oncology, necessitates robust genomic profiling tools to guide therapeutic decisions, with the American Cancer Society projecting 2,041,910 new cancer cases in the United States in 2025. This substantial disease burden drives the necessity for expression analysis, yet the market faces a significant challenge regarding the interpretation of complex large-scale data. The scarcity of skilled bioinformatics professionals required to analyze these vast datasets serves as a major bottleneck that could impede the full expansion of the Global Gene Expression Analysis Market.

Market Driver

Technological advancements in Next-Generation Sequencing (NGS) and PCR platforms are fundamentally transforming the Global Gene Expression Analysis Market by improving throughput and simplifying genomic profiling. These innovations empower laboratories to process extensive biological data with remarkable speed and accuracy, thereby accelerating the integration of expression analysis into clinical and research environments. High-performance sequencing devices have been a key driver for market expansion, as demonstrated by leading innovators; Oxford Nanopore Technologies reported 23% underlying revenue growth on a constant currency basis in its 2024 annual results, largely due to new sensing platform adoption, while Illumina recorded full-year 2024 revenue of $4.3 billion, highlighting significant global demand for advanced genomic infrastructure.

Furthermore, robust government funding and private investment in genomic research serve as another critical driver, supplying essential capital for scaling precision medicine initiatives and population health studies. Public sector commitments are crucial for biomarker validation and embedding gene expression profiling into national healthcare systems, mitigating risks in new diagnostic tool development. These investments foster a stable growth environment, ensuring long-term project viability, exemplified by the UK Government's significant £650 million investment by 2030 to advance genomic medicine and expand newborn sequencing, which not only speeds up gene-disease association discovery but also mandates broader use of expression analysis technologies in public health.

Market Challenge

The Global Gene Expression Analysis Market is significantly constrained by a scarcity of skilled bioinformatics professionals. Despite the rapid acceleration in genomic data generation, the ability to process and interpret this vast information has lagged, creating a bottleneck where substantial volumes of expression data remain underutilized. This gap delays the conversion of raw sequencing results into actionable biological insights, hindering pharmaceutical companies and research institutions in efficiently validating biomarkers and thereby slowing drug development and clinical applications.

This shortage of specialized talent elevates operational costs and extends project timelines, as organizations compete for a limited pool of experts capable of managing complex high-throughput expression data analysis. According to the Pistoia Alliance in 2025, 34% of life science professionals identified a lack of skilled personnel as a major impediment to adopting advanced data analysis technologies, thus preventing the market from achieving its full scalability across healthcare and research sectors.

Market Trends

The integration of Artificial Intelligence (AI) and Machine Learning (ML) in data analysis is rapidly enhancing market value by transforming intricate genomic datasets into actionable insights. With the exponential growth of gene expression data, AI-driven platforms are increasingly replacing traditional bioinformatics methods, efficiently identifying novel biomarkers and therapeutic targets. This trend validates a commercial model where advanced data interpretation is as crucial as sequencing, directly addressing the challenge of data complexity, as demonstrated by Tempus AI, Inc. reporting total revenue of $693.4 million in 2024, with 30.4% year-over-year growth primarily from algorithmic data services.

Concurrently, the widespread adoption of spatial transcriptomics for tissue mapping is revolutionizing biological research by enabling the visualization of gene activity within the precise physical architecture of tissues. This method overcomes bulk sequencing limitations by maintaining spatial context, which is vital for understanding complex conditions such as the tumor microenvironment. The market is also seeing a significant increase in specialized hardware installations for these high-resolution studies, establishing a lasting infrastructure for single-cell and spatial biology; 10x Genomics, Inc., for instance, reported over 7,000 cumulative instruments sold by the end of 2024, highlighting the growing penetration of these advanced tools in global laboratories.

Key Market Players

  • Merck KGaA
  • Genscript Biotech Corporation
  • Qiagen N.V.
  • Bio-Rad Laboratories Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • Promega Corporation
  • Agilent Technologies Inc.
  • Lonza Group Ltd.
  • New England Biolabs Inc

Report Scope

In this report, the Global Gene Expression Analysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gene Expression Analysis Market, By Product Type

  • Instruments
  • Services
  • Others

Gene Expression Analysis Market, By Technique

  • RNA Expression
  • Promotor Analysis
  • Protein Expression & Post Translational Modification Expression
  • Others

Gene Expression Analysis Market, By Application

  • Drug Discovery and Development
  • Clinical Diagnostics
  • Biotechnology and Microbiology
  • Others

Gene Expression Analysis Market, By End User

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic and Government Research Institutes
  • Others

Gene Expression Analysis Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Gene Expression Analysis Market.

Available Customizations:

Global Gene Expression Analysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Gene Expression Analysis Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Instruments, Services, Others)
    • 5.2.2. By Technique (RNA Expression, Promotor Analysis, Protein Expression & Post Translational Modification Expression, Others)
    • 5.2.3. By Application (Drug Discovery and Development, Clinical Diagnostics, Biotechnology and Microbiology, Others)
    • 5.2.4. By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Government Research Institutes, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Gene Expression Analysis Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Technique
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Gene Expression Analysis Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Gene Expression Analysis Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Gene Expression Analysis Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Gene Expression Analysis Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Technique
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Gene Expression Analysis Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. France Gene Expression Analysis Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Gene Expression Analysis Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Gene Expression Analysis Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Technique
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Gene Expression Analysis Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Technique
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia Pacific Gene Expression Analysis Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Technique
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Gene Expression Analysis Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Gene Expression Analysis Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Gene Expression Analysis Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Gene Expression Analysis Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Gene Expression Analysis Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Middle East & Africa Gene Expression Analysis Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Technique
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Gene Expression Analysis Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Gene Expression Analysis Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Gene Expression Analysis Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. South America Gene Expression Analysis Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Technique
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Gene Expression Analysis Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Gene Expression Analysis Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Gene Expression Analysis Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Gene Expression Analysis Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Merck KGaA
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Genscript Biotech Corporation
  • 15.3. Qiagen N.V.
  • 15.4. Bio-Rad Laboratories Inc.
  • 15.5. Takara Bio Inc.
  • 15.6. Thermo Fisher Scientific, Inc.
  • 15.7. Promega Corporation
  • 15.8. Agilent Technologies Inc.
  • 15.9. Lonza Group Ltd.
  • 15.10. New England Biolabs Inc

16. Strategic Recommendations

17. About Us & Disclaimer